{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:57:29Z","timestamp":1792094249369,"version":"4.4.0"},"reference-count":228,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Atherosclerosis is considered a disease caused by a chronic inflammation, associated with endothelial dysfunction, and several mediators of inflammation are up-regulated in subjects with atherosclerotic disease. Healthy, intact endothelium exhibits an antithrombotic, protective surface between the vascular lumen and vascular smooth muscle cells in the vessel wall. Oxidative stress is an imbalance between anti- and prooxidants, with a subsequent increase of reactive oxygen species, leading to tissue damage. The renin-angiotensin-aldosterone system is of vital importance in the pathobiology of vascular disease. Convincing data indicate that angiotensin II accelerates hypertension and augments the production of reactive oxygen species. This leads to the generation of a proinflammatory phenotype in human endothelial and vascular smooth muscle cells by the up-regulation of adhesion molecules, chemokines and cytokines. In addition, angiotensin II also seems to increase thrombin generation, possibly\n                    <jats:italic>via<\/jats:italic>\n                    a direct impact on tissue factor. However, the mechanism of cross-talk between inflammation and haemostasis can also contribute to prothrombotic states in inflammatory environments. Thus, blocking of the renin-angiotensin-aldosterone system might be an approach to reduce both inflammatory and thrombotic complications in high-risk patients. During COVID-19, the renin-angiotensin-aldosterone system may be activated. The levels of angiotensin II could contribute to the ongoing inflammation, which might result in a cytokine storm, a complication that significantly impairs prognosis. At the outbreak of COVID-19 concerns were raised about the use of angiotensin converting enzyme inhibitors and angiotensin receptor blocker drugs in patients with COVID-19 and hypertension or other cardiovascular comorbidities. However, the present evidence is in favor of continuing to use of these drugs. Based on experimental evidence, blocking the renin-angiotensin-aldosterone system might even exert a potentially protective influence in the setting of COVID-19.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2021.640185","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T01:46:51Z","timestamp":1623894411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19"],"prefix":"10.3389","volume":"12","author":[{"given":"M.","family":"Ekholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/13543776.2018.1531848","article-title":"Chymase Inhibitors for the Treatment of Cardiac Diseases: a Patent Review (2010-2018)","volume":"28","author":"Ahmad","year":"2018","journal-title":"Expert Opin. Ther. Patents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.vph.2014.06.001","article-title":"Functional Role of Protease Activated Receptors in Vascular Biology","volume":"62","author":"Alberelli","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 Ligand System","volume":"54","author":"Antoniades","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.2741\/2285","article-title":"Plasminogen Activator Inhibitor (PAI)-1 in Vascular Inflammation and Thrombosis","volume":"12","author":"Aso","year":"2007","journal-title":"Front. Biosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, Angiotensin-(1-7), and Mas: the Other Side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1182\/blood-2002-03-0902","article-title":"Platelets, Circulating Tissue Factor, and Fibrin Colocalize in Ex Vivo Thrombi: Real-Time Fluorescence Images of Thrombus Formation and Propagation under Defined Flow Conditions","volume":"100","author":"Balasubramanian","year":"2002","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"H1769","DOI":"10.1152\/ajpheart.1997.273.4.H1769","article-title":"Angiotensin II Formation from ACE and Chymase in Human and Animal Hearts: Methods and Species Considerations","volume":"273","author":"Balcells","year":"1997","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/hjh.0000000000002784","article-title":"Renin-angiotensin-system Inhibitors and All-Cause Mortality in Patients with COVID-19: a Systematic Review and Meta-Analysis of Observational Studies","volume":"39","author":"Bavishi","year":"2021","journal-title":"J. Hypertens."},{"key":"B10","doi-asserted-by":"publisher","first-page":"32188","DOI":"10.1038\/srep32188","article-title":"Effects of IL-1\u03b2, IL-6 and IL-8 on Erythrocytes, Platelets and Clot Viscoelasticity","volume":"6","author":"Bester","year":"2016","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet \u03b1-granules: Basic Biology and Clinical Correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.Hyp.0000077901.84467.E1","article-title":"Pharmacological Modulation of Platelet Function in Hypertension","volume":"42","author":"Blann","year":"2003","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nm841","article-title":"Alternatively Spliced Human Tissue Factor: a Circulating, Soluble, Thrombogenic Protein","volume":"9","author":"Bogdanov","year":"2003","journal-title":"Nat. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1570161111311020005","article-title":"Endothelial Dysfunction in Sepsis","volume":"11","author":"Boisram\u00e9-Helms","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0037-1612991","article-title":"Improved Fibrinolysis after One Year of Treatment with Enalapril in Men and Women with Uncomplicated Myocardial Infarction","volume":"87","author":"Boman","year":"2002","journal-title":"Thromb. Haemost."},{"key":"B16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1182\/blood-2010-05-285627","article-title":"No Evidence for Tissue Factor on Platelets","volume":"116","author":"Bouchard","year":"2010","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1161\/01.atv.0000021412.56621.a2","article-title":"Vascular Inflammation and the Renin-Angiotensin System","volume":"22","author":"Brasier","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"18s","DOI":"10.1378\/chest.124.3_suppl.18s","article-title":"Thrombin and Platelet Activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest"},{"key":"B19","first-page":"419","article-title":"Prothrombotic Effects of Angiotensin","volume":"45","author":"Brown","year":"2000","journal-title":"Adv. Intern. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.thromres.2019.08.015","article-title":"The Circadian Rhythm of Selected Parameters of the Hemostasis System in Healthy People","volume":"182","author":"Budkowska","year":"2019","journal-title":"Thromb. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1161\/atvbaha.110.222703","article-title":"Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I\/NADPH Oxidase\/Rho Kinase Pathways Targeted to Lipid Rafts","volume":"31","author":"Burger","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","article-title":"Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II\u2013Induced Cardiac Hypertrophy","volume":"93","author":"Byrne","year":"2003","journal-title":"Circ. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.Cir.0000096055.62724.C5","article-title":"Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells","volume":"108","author":"Calabr\u00f3","year":"2003","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1182\/blood-2010-09-307306","article-title":"Tissue Factor Expression on Platelets Is a Dynamic Event","volume":"116","author":"Camera","year":"2010","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: Immunopathology and its Implications for Therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/circresaha.108.174235","article-title":"Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte Adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.14336\/ad.2015.0803","article-title":"Chronic Inflammatory Diseases and Endothelial Dysfunction","volume":"7","author":"Castellon","year":"2016","journal-title":"Aging Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/0929866023408779","article-title":"The Systemic Reaction during Inflammation: the Acute-phase Proteins","volume":"9","author":"Ceciliani","year":"2002","journal-title":"Protein Pept. Lett."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/jci137244","article-title":"Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019","volume":"130","author":"Chen","year":"","journal-title":"J. Clin. Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s0140-6736(20)30211-7","article-title":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: a Descriptive Study","volume":"395","author":"Chen","year":"","journal-title":"The Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1089\/ars.2013.5620","article-title":"The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls","volume":"20","author":"Cifuentes-Pagano","year":"2014","journal-title":"Antioxid. Redox Signaling"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/cvr\/cvz230","article-title":"Oxidized Low-Density Lipoproteins Induce Tissue Factor Expression in T-Lymphocytes via Activation of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1","volume":"116","author":"Cimmino","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11239-015-1199-1","article-title":"Reactive Oxygen Species Induce a Procoagulant State in Endothelial Cells by Inhibiting Tissue Factor Pathway Inhibitor","volume":"40","author":"Cimmino","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1586\/erc.11.40","article-title":"The Missing Link between Atherosclerosis, Inflammation and Thrombosis: Is it Tissue Factor?","volume":"9","author":"Cimmino","year":"2011","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1161\/01.cir.0000129312.43547.08","article-title":"Tissue Factor Binding of Activated Factor VII Triggers Smooth Muscle Cell Proliferation via Extracellular Signal-Regulated Kinase Activation","volume":"109","author":"Cirillo","year":"2004","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cardiores.2005.05.010","article-title":"C-reactive Protein Induces Tissue Factor Expression and Promotes Smooth Muscle and Endothelial Cell Proliferation","volume":"68","author":"Cirillo","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/j.thromres.2013.01.019","article-title":"Angiotensin II Induces the Generation of Procoagulant Microparticles by Human Mononuclear Cells via an Angiotensin Type 2 Receptor-Mediated Pathway","volume":"131","author":"Cordazzo","year":"2013","journal-title":"Thromb. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin Signalling and Protease-Activated Receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mcn.2012.11.001","article-title":"Cu-Zn Superoxide Dismutase Activates Muscarinic Acetylcholine M1 Receptor Pathway in Neuroblastoma Cells","volume":"52","author":"Damiano","year":"2013","journal-title":"Mol. Cell Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/hypertensionaha.120.15082","article-title":"Renin-Angiotensin System Blockers and the COVID-19 Pandemic","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.3390\/ijms21228533","article-title":"CD40\/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease-The Pros and Cons for Cardioprotection","volume":"21","author":"Daub","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B42","article-title":"Inflammation and Acute Phase Proteins in Haemostasis","volume-title":"Acute Phase Proteins","author":"Davidson","year":"2013"},{"key":"B43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MOH.0b013e32832ea49c","article-title":"Microparticles and Thrombotic Disease","volume":"16","author":"Davizon","year":"2009","journal-title":"Curr. Opin. Hematol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/cdli.10.3.495-497.2003","article-title":"Activation of Coagulation by Administration of Recombinant Factor VIIa Elicits Interleukin 6 (IL-6) and IL-8 Release in Healthy Human Subjects","volume":"10","author":"de Jonge","year":"2003","journal-title":"Clin. Vaccin. Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.peptides.2011.06.018","article-title":"On the Local Cardiac Renin Angiotensin System. Basic and Clinical Implications","volume":"32","author":"De Mello","year":"2011","journal-title":"Peptides"},{"key":"B46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1470320310379449","article-title":"Aliskiren, a Renin Inhibitor, Downregulates TNF-\u03b1-Induced Tissue Factor Expression in HUVECS","volume":"11","author":"Del Fiorentino","year":"2010","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"B47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/circresaha.117.310978","article-title":"Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling","volume":"122","author":"Dell'Italia","year":"2018","journal-title":"Circ. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/circresaha.110.238550","article-title":"Translational success Stories: Angiotensin Receptor 1 Antagonists in Heart Failure","volume":"109","author":"Dell'Italia","year":"2011","journal-title":"Circ. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.cir.0000052617.91920.fd","article-title":"C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells","volume":"107","author":"Devaraj","year":"2003","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1001\/jama.2012.6571","article-title":"Lipid-related Markers and Cardiovascular Disease Prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"Jama"},{"key":"B51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.Hyp.0000227932.13687.60","article-title":"Genetic Basis of Hypertension","volume":"48","author":"Dickson","year":"2006","journal-title":"Hypertension"},{"key":"B52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 Family in Innate Inflammation and Acquired Immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1124\/mol.116.106666","article-title":"Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets","volume":"91","author":"Duvernay","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1182\/blood-2007-08-107698","article-title":"Granulocytes Do Not Express but Acquire Monocyte-Derived Tissue Factor in Whole Blood: Evidence for a Direct Transfer","volume":"111","author":"Egorina","year":"2008","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/fjc.0000000000000565","article-title":"Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension","volume":"71","author":"Ekholm","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1470320315575848","article-title":"Haemostatic and Inflammatory Alterations in Familial Hypercholesterolaemia, and the Impact of Angiotensin II Infusion","volume":"16","author":"Ekholm","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"B57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.thromres.2008.12.040","article-title":"Angiotensin II Infusion in Man Is Proinflammatory but Has No Short-Term Effects on Thrombin Generation In Vivo","volume":"124","author":"Ekholm","year":"2009","journal-title":"Thromb. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/mbc.0000000000000393","article-title":"Infusion of Angiotensin II Increases Fibrinolysis in Healthy Individuals but Not in Patients with Familial Combined Hyperlipidemia","volume":"27","author":"Ekholm","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1042\/cs1030151","article-title":"Long-term Angiotensin-Converting Enzyme Inhibition with Ramipril Reduces Thrombin Generation in Human Hypertension","volume":"103","author":"Ekholm","year":"2002","journal-title":"Clin. Sci. (Lond)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"26s","DOI":"10.1378\/chest.124.3_suppl.26s","article-title":"The Protein C Pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"key":"B61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/s0002-9149(03)00657-x","article-title":"Relation of Thrombogenesis in Systemic Hypertension to Angiogenesis and Endothelial Damage\/dysfunction (A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])","volume":"92","author":"Felmeden","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.jaad.2020.04.093","article-title":"Characterization of Acute Acral Skin Lesions in Nonhospitalized Patients: A Case Series of 132 Patients during the COVID-19 Outbreak","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac Remodelling and RAS Inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/circulationaha.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/13543776.2012.682572","article-title":"Therapeutic Targeting of the Angiotensin-Converting Enzyme 2\/Angiotensin-(1-7)\/Mas cascade in the Renin-Angiotensin System: a Patent Review","volume":"22","author":"Ferreira","year":"2012","journal-title":"Expert Opin. Ther. Patents"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE Inhibitors or ARBs and Risk of Severe\/lethal COVID-19: a Meta-Analysis","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"},{"key":"B67","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1160\/th13-06-0448","article-title":"Treatment with Angiotensin-(1-7) Reduces Inflammation in Carotid Atherosclerotic Plaques","volume":"111","author":"Fraga-Silva","year":"2014","journal-title":"Thromb. Haemost."},{"key":"B68","doi-asserted-by":"publisher","first-page":"H223","DOI":"10.1152\/ajpheart.00534.2016","article-title":"Chymase-dependent Production of Angiotensin II: an Old Enzyme in Old Hearts","volume":"312","author":"Froogh","year":"2017","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.4049\/jimmunol.1601223","article-title":"Highly Selective Cleavage of Cytokines and Chemokines by the Human Mast Cell Chymase and Neutrophil Cathepsin G","volume":"198","author":"Fu","year":"2017","journal-title":"J. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellsig.2018.06.007","article-title":"Angiotensin (1-7) Does Not Interact Directly with MAS1, but Can Potently Antagonize Signaling from the AT1 Receptor","volume":"50","author":"Gaidarov","year":"2018","journal-title":"Cell Signal."},{"key":"B71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast Cells in the Development of Adaptive Immune Responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID\u201019","volume":"92","author":"Gao","year":"2020","journal-title":"J. Med. Virol."},{"key":"B73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0037-1613203","article-title":"Transient Platelet Interaction Induces MCP-1 Production by Endothelial Cells via I Kappa B Kinase Complex Activation","volume":"88","author":"Gawaz","year":"2002","journal-title":"Thromb. Haemost."},{"key":"B74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0021-9150(99)00241-5","article-title":"Platelets Induce Alterations of Chemotactic and Adhesive Properties of Endothelial Cells Mediated through an Interleukin-1-dependent Mechanism. Implications for Atherogenesis","volume":"148","author":"Gawaz","year":"2000","journal-title":"Atherosclerosis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1172\/jci27196","article-title":"Platelets in Inflammation and Atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ajh.2009.247","article-title":"Platelet Activation in Essential Hypertension: Implications for Antiplatelet Treatment","volume":"23","author":"Gkaliagkousi","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"B77","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/atvbaha.117.309846","article-title":"Tissue Factor","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.yjmcc.2005.06.012","article-title":"A Negative Feedback Mechanism Involving Nitric Oxide and Nuclear Factor Kappa-B Modulates Endothelial Nitric Oxide Synthase Transcription","volume":"39","author":"Grumbach","year":"2005","journal-title":"J. Mol. Cell Cardiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1161\/circulationaha.106.638478","article-title":"Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans","volume":"114","author":"Gudmundsd\u00f3ttir","year":"2006","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000338166","article-title":"Inflammatory Cytokines in Heart Failure: Mediators and Markers","volume":"122","author":"Gullestad","year":"2012","journal-title":"Cardiology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/hypertensionaha.109.141622","article-title":"Angiotensin-(1-7)-angiotensin-converting Enzyme 2 Attenuates Reactive Oxygen Species Formation to Angiotensin II within the Cell Nucleus","volume":"55","author":"Gwathmey","year":"2010","journal-title":"Hypertension"},{"key":"B83","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.thromres.2005.04.033","article-title":"Angiotensin II Induces the Expression of Tissue Factor and its Mechanism in Human Monocytes","volume":"117","author":"He","year":"2006","journal-title":"Thromb. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00228-020-02915-y","article-title":"A Novel Mechanism of ACE Inhibition-Associated Enhanced Platelet Reactivity: Disproof of the ARB-MI Paradox?","volume":"76","author":"Helten","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/01.ATV.0000112024.13727.2c","article-title":"Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells","volume":"24","author":"Hilenski","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of Severe COVID-19 Disease with ACE Inhibitors and Angiotensin Receptor Blockers: Cohort Study Including 8.3 Million People","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"key":"B88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.ATV.0000251995.73307.2d","article-title":"The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology","volume":"27","author":"Hirano","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00395-017-0652-z","article-title":"Dual Inhibition of Cathepsin G and Chymase Reduces Myocyte Death and Improves Cardiac Remodeling after Myocardial Ischemia Reperfusion Injury","volume":"112","author":"Hooshdaran","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1038\/ncomms4595","article-title":"Angiotensin II Plasma Levels Are Linked to Disease Severity and Predict Fatal Outcomes in H7N9-Infected Patients","volume":"5","author":"Huang","year":"2014","journal-title":"Nat. Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1182\/blood.v99.10.3637","article-title":"Tissue-type Plasminogen Activator (t-PA) Is Stored in Weibel-Palade Bodies in Human Endothelial Cells Both In Vitro and In Vivo","volume":"99","author":"Huber","year":"2002","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting Enzyme 2 Protects from Severe Acute Lung Failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/0002-9149(92)90799-5","article-title":"Circadian Variation in Platelet Function in Healthy Volunteers","volume":"69","author":"Jafri","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s0008-6363(03)00535-2","article-title":"Impact of Chymase Inhibitor on Cardiac Function and Survival after Myocardial Infarction","volume":"60","author":"Jin","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s00395-007-0667-y","article-title":"Endotoxin-induced Effects on Platelets and Monocytes in an In Vivo Model of Inflammation","volume":"102","author":"K\u00e4lsch","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejcts.2007.09.040","article-title":"Chronic Chymase Inhibition Preserves Cardiac Function after Left Ventricular Repair in Rats","volume":"33","author":"Kanemitsu","year":"2008","journal-title":"Eur. J. Cardio-Thoracic Surg."},{"key":"B97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/01.cir.96.1.19","article-title":"Morning Hypercoagulability and Hypofibrinolysis","volume":"96","author":"Kapiotis","year":"1997","journal-title":"Circulation"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/circulationaha.108.784868","article-title":"Angiotensin II Type 2 Receptor Stimulation","volume":"118","author":"Kaschina","year":"2008","journal-title":"Circulation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1172\/jci118312","article-title":"Angiotensin Induction of PAI-1 Expression in Endothelial Cells Is Mediated by the Hexapeptide Angiotensin IV","volume":"96","author":"Kerins","year":"1995","journal-title":"J. Clin. Invest."},{"key":"B101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.07.008","article-title":"Angiotensin II Type 1 Receptor Blockers Reduce Tissue Factor Activity and Plasminogen Activator Inhibitor Type-1 Antigen in Hypertensive Patients: a Randomized, Double-Blind, Placebo-Controlled Study","volume":"177","author":"Koh","year":"2004","journal-title":"Atherosclerosis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2017.10.013","article-title":"Mast Cells in Atherosclerotic Cardiovascular Disease - Activators and Actions","volume":"816","author":"Kovanen","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/s1734-1140(12)70944-1","article-title":"Different Effects of Perindopril and Enalapril on Monocyte Cytokine Release in Coronary Artery Disease Patients with normal Blood Pressure","volume":"64","author":"Krysiak","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast Cell: A Multi-Functional Master Cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/cs20120089","article-title":"The Intracrine Renin-Angiotensin System","volume":"123","author":"Kumar","year":"2012","journal-title":"Clin. Sci. (Lond)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri1312","article-title":"NOX Enzymes and the Biology of Reactive Oxygen","volume":"4","author":"Lambeth","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/hypertensionaha.118.11168","article-title":"AT 2 R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat","volume":"72","author":"Lange","year":"2018","journal-title":"Hypertension"},{"key":"B108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00001721-199901000-00003","article-title":"Acute Effects of Angiotensin II on Fibrinolysis in Healthy Volunteers","volume":"10","author":"Larsson","year":"1999","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00001721-200011010-00007","article-title":"Platelet Activation during Angiotensin II Infusion in Healthy Volunteers","volume":"11","author":"Larsson","year":"2000","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","article-title":"Vascular NAD(P)H Oxidases: Specific Features, Expression, and Regulation","volume":"285","author":"Lass\u00e8gue","year":"2003","journal-title":"Am. J. Physiology-Regulatory, Integr. Comp. Physiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/eurheartj\/ehi733","article-title":"Economic burden of Cardiovascular Diseases in the Enlarged European Union","volume":"27","author":"Leal","year":"2006","journal-title":"Eur. Heart J."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00134-020-06059-6","article-title":"Facing COVID-19 in the ICU: Vascular Dysfunction, Thrombosis, and Dysregulated Inflammation","volume":"46","author":"Leisman","year":"2020","journal-title":"Intensive Care Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2362.1997.570614.x","article-title":"The Cytokine-Mediated Imbalance between Coagulant and Anticoagulant Mechanisms in Sepsis and Endotoxaemia","volume":"27","author":"Levi","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"B114","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1055\/s-0032-1305782","article-title":"Infection and Inflammation as Risk Factors for Thrombosis and Atherosclerosis","volume":"38","author":"Levi","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1074\/jbc.M806010200","article-title":"NF-\u03baB Transcription Factor P50 Critically Regulates Tissue Factor in Deep Vein Thrombosis","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"H2116","DOI":"10.1152\/ajpheart.00551.2005","article-title":"ANG II Induces Apoptosis of Human Vascular Smooth Muscle via Extrinsic Pathway Involving Inhibition of Akt Phosphorylation and Increased FasL Expression","volume":"290","author":"Li","year":"2006","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/circulationaha.120.047549","article-title":"The Science Underlying COVID-19","volume":"142","author":"Liu","year":"","journal-title":"Circulation"},{"key":"B118","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and Biochemical Indexes from 2019-nCoV Infected Patients Linked to Viral Loads and Lung Injury","volume":"63","author":"Liu","year":"","journal-title":"Sci. China Life Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrcardio.2010.136","article-title":"The Role of Rho Protein Signaling in Hypertension","volume":"7","author":"Loirand","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1081\/ceh-120027328","article-title":"Short\u2010Term Effects of Exogenous Angiotensin II on Plasma Fibrinolytic Balance in Normal Subjects","volume":"26","author":"Lottermoser","year":"2004","journal-title":"Clin. Exp. Hypertens."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1476-5381.2011.01712.x","article-title":"Comparative Effects of Different Modes of Renin Angiotensin System Inhibition on Hypercholesterolaemia-Induced Atherosclerosis","volume":"165","author":"Lu","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1055\/s-0038-1657623","article-title":"Regulation of the Tissue Factor Gene","volume":"78","author":"Mackman","year":"1997","journal-title":"Thromb. Haemost."},{"key":"B123","doi-asserted-by":"publisher","first-page":"686","DOI":"10.5414\/cpp47686","article-title":"The Effects of 1 Month Antihypertensive Treatment with Perindopril, Bisoprolol or Both on the Ex Vivo Ability of Monocytes to Secrete Inflammatory Cytokines","volume":"47","author":"Madej","year":"2009","journal-title":"Cp"},{"key":"B124","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.2040-1124.2012.00202.x","article-title":"Chymase Inhibition Prevents Myocardial Fibrosis through the Attenuation of NOX4-Associated Oxidative Stress in Diabetic Hamsters","volume":"3","author":"Maeda","year":"2012","journal-title":"J. Diabetes Investig."},{"key":"B125","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.cir.101.8.841","article-title":"Elevated Levels of Shed Membrane Microparticles with Procoagulant Potential in the Peripheral Circulating Blood of Patients with Acute Coronary Syndromes","volume":"101","author":"Mallat","year":"2000","journal-title":"Circulation"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/00004872-200106000-00023","article-title":"Regression of Left Ventricular Hypertrophy in Human Hypertension with Irbesartan","volume":"19","author":"Malmqvist","year":"2001","journal-title":"J. Hypertens."},{"key":"B127","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of Inflammasome Activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2012.06.021","article-title":"Adipose Tissue Renin-Angiotensin-Aldosterone System (RAAS) and Progression of Insulin Resistance","volume":"378","author":"Marcus","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.4049\/jimmunol.167.6.3435","article-title":"The IL-6-Soluble IL-6R\u03b1 Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin","volume":"167","author":"Marin","year":"2001","journal-title":"J. Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2020.04.044","article-title":"Varicella-like Exanthem as a Specific COVID-19-Associated Skin Manifestation: Multicenter Case Series of 22 Patients","volume":"83","author":"Marzano","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/fjc.0000000000000208","article-title":"AT2 Receptor Activities and Pathophysiological Implications","volume":"65","author":"Matavelli","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of Global Mortality and burden of Disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"Plos Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1161\/01.Cir.0000074041.81728.79","article-title":"Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure","volume":"107","author":"Matsumoto","year":"2003","journal-title":"Circulation"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1161\/01.cir.0000131860.80444.ab","article-title":"Aldosterone Potentiates Angiotensin II-Induced Signaling in Vascular Smooth Muscle Cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the Master Regulator of Fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cardiores.2007.07.008","article-title":"Cross-talk between Aldosterone and Angiotensin II in Vascular Smooth Muscle Cell Senescence","volume":"76","author":"Min","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive Oxygen Species in Inflammation and Tissue Injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signaling"},{"key":"B139","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1084\/jem.174.4.821","article-title":"Rapid and Specific Conversion of Precursor Interleukin 1 Beta (IL-1 Beta) to an Active IL-1 Species by Human Mast Cell Chymase","volume":"174","author":"Mizutani","year":"1991","journal-title":"J. Exp. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1242\/jcs.02579","article-title":"The NF-\u03baB Pathway","volume":"118","author":"Moynagh","year":"2005","journal-title":"J. Cel Sci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"15745","DOI":"10.1074\/jbc.M112.439844","article-title":"NADPH Oxidase 4 Regulates Cardiomyocyte Differentiation via Redox Activation of C-Jun Protein and the Cis-Regulation of GATA-4 Gene Transcription","volume":"288","author":"Murray","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B142","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1046\/j.1523-1755.2000.00160.x","article-title":"Plasminogen Activator Inhibitor-1 Expression Is Regulated by the Angiotensin Type 1 Receptor In Vivo1","volume":"58","author":"Nakamura","year":"2000","journal-title":"Kidney Int."},{"key":"B143","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1291\/hypres.28.925","article-title":"Cardioprotective Mechanisms of Spironolactone Associated with the Angiotensin-Converting Enzyme\/epidermal Growth Factor Receptor\/extracellular Signal-Regulated Kinases, NAD(P)H Oxidase\/lectin-like Oxidized Low-Density Lipoprotein Receptor-1, and Rho-Kinase Pathways in Aldosterone\/salt-Induced Hypertensive Rats","volume":"28","author":"Nakano","year":"2005","journal-title":"Hypertens. Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/01.res.86.2.139","article-title":"Angiotensin-converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes","volume":"86","author":"Napoleone","year":"2000","journal-title":"Circ. Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jcdd6020014","article-title":"An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"B146","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11739-009-0297-5","article-title":"The Microcirculation as a Diagnostic and Therapeutic Target in Sepsis","volume":"4","author":"Nencioni","year":"2009","journal-title":"Intern. Emerg. Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00467-007-0636-6","article-title":"Role of the Renin Angiotensin System in TNF-\u03b1 and Shiga-Toxin-Induced Tissue Factor Expression","volume":"23","author":"Nestoridi","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature","volume":"19","author":"Nguyen Dinh Cat","year":"2013","journal-title":"Antioxid. Redox Signaling"},{"key":"B149","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1038\/sj.jhh.1001436","article-title":"Central Role of the AT1-Receptor in Atherosclerosis","volume":"16","author":"Nickenig","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1055\/s-0038-1656136","article-title":"Angiotensin II Increases Plasminogen Activator Inhibitor-1 and Tissue Factor mRNA Expression without Changing that of Tissue Type Plasminogen Activator or Tissue Factor Pathway Inhibitor in Cultured Rat Aortic Endothelial Cells","volume":"77","author":"Nishimura","year":"1997","journal-title":"Thromb. Haemost."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/hypertensionaha.108.110932","article-title":"Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression","volume":"51","author":"Nussberger","year":"2008","journal-title":"Hypertension"},{"key":"B152","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1292\/jvms.09-0582","article-title":"Angiotensin 11 Enhances Interleukin-1.BETA.-Induced MMP-9 Secretion in Adult Rat Cardiac Fibroblasts","volume":"72","author":"Okada","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.thromres.2013.04.010","article-title":"Human Platelets Do Not Express Tissue Factor","volume":"132","author":"\u00d8sterud","year":"2013","journal-title":"Thromb. Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1124\/jpet.111.179697","article-title":"Chymase Inhibition Reduces Infarction and Matrix Metalloproteinase-9 Activation and Attenuates Inflammation and Fibrosis after Acute Myocardial Ischemia\/reperfusion","volume":"339","author":"Oyamada","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B155","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0895-7061(01)02291-9","article-title":"Cardiac and Vascular Fibrosis and Hypertrophy in Aldosterone-Infused Rats: Role of Endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"B156","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11906-020-01101-w","article-title":"Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities","volume":"22","author":"Patoulias","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"B157","doi-asserted-by":"publisher","first-page":"107511","DOI":"10.1016\/j.pharmthera.2020.107511","article-title":"Targeting the NLRP3 Inflammasome to Treat Cardiovascular Fibrosis","volume":"209","author":"Pinar","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P-Selectin, Tissue Factor, Coagulation Triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"B159","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac Fibroblasts: at the Heart of Myocardial Remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"B160","doi-asserted-by":"publisher","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","article-title":"The Renin-Angiotensin System: a Target of and Contributor to Dyslipidemias, Altered Glucose Homeostasis, and Hypertension of the Metabolic Syndrome","volume":"302","author":"Putnam","year":"2012","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1113\/expphysiol.2011.060673","article-title":"Moderate Cardiac-Selective Overexpression of Angiotensin II Type 2 Receptor Protects Cardiac Functions from Ischaemic Injury","volume":"97","author":"Qi","year":"2012","journal-title":"Exp. Physiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphys.2012.00003","article-title":"Exogenous, but Not Endogenous Nitric Oxide Inhibits Adhesion Molecule Expression in Human Endothelial Cells","volume":"3","author":"Qian","year":"2012","journal-title":"Front. Physio."},{"key":"B163","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature06796","article-title":"Translating Molecular Discoveries into New Therapies for Atherosclerosis","volume":"451","author":"Rader","year":"2008","journal-title":"Nature"},{"key":"B164","first-page":"927","article-title":"Atherosclerosis: Process, Indicators, Risk Factors and New Hopes","volume":"5","author":"Rafieian-Kopaei","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"B165","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.162.9.5466","article-title":"Thrombin-induced P65 Homodimer Binding to Downstream NF-Kappa B Site of the Promoter Mediates Endothelial ICAM-1 Expression and Neutrophil Adhesion","volume":"162","author":"Rahman","year":"1999","journal-title":"J. Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.thromres.2012.02.021","article-title":"Tissue Factor Encryption and Decryption: Facts and Controversies","volume":"129","author":"Rao","year":"2012","journal-title":"Thromb. Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.steroids.2011.02.015","article-title":"Cross-talk between Aldosterone and Angiotensin Signaling in Vascular Smooth Muscle Cells","volume":"76","author":"Rautureau","year":"2011","journal-title":"Steroids"},{"key":"B168","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/01.cir.97.5.425","article-title":"Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/01.cir.87.6.1969","article-title":"Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II. Evidence of a Potential Interaction between the Renin-Angiotensin System and Fibrinolytic Function","volume":"87","author":"Ridker","year":"1993","journal-title":"Circulation"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.cir.101.15.1767","article-title":"Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 Trans-signaling via the Soluble IL-6 Receptor: Importance for the Pro-inflammatory Activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"B172","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B173","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-dependent Pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"B174","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bph.13063","article-title":"Compound 21, a Selective Agonist of Angiotensin AT2receptors, Prevents Endothelial Inflammation and Leukocyte Adhesionin Vitroandin Vivo","volume":"173","author":"Sampson","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The Endothelium and its Role in Regulating Vascular Tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc. Med. J."},{"key":"B176","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fphys.2015.00194","article-title":"NOX Signaling in Molecular Cardiovascular Mechanisms Involved in the Blood Pressure Homeostasis","volume":"6","author":"Santillo","year":"2015","journal-title":"Front. Physiol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) Is an Endogenous Ligand for the G Protein-Coupled Receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Pnas"},{"key":"B178","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1182\/blood-2006-04-014175","article-title":"Thrombin-induced Endothelial Microparticle Generation: Identification of a Novel Pathway Involving ROCK-II Activation by Caspase-2","volume":"108","author":"Sapet","year":"2006","journal-title":"Blood"},{"key":"B180","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/01.RES.78.2.225","article-title":"Nitric Oxide Reversibly Inhibits the Migration of Cultured Vascular Smooth Muscle Cells","volume":"78","author":"Sarkar","year":"1996","journal-title":"Circ. Res."},{"key":"B181","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.hyp.38.1.90","article-title":"Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients with Essential Hypertension","volume":"38","author":"Sasaki","year":"2001","journal-title":"Hypertension"},{"key":"B182","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/00005344-200101000-00013","article-title":"Role of Endogenous Angiotensin II in the Increased Expression of Growth Factors in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats","volume":"37","author":"Satoh","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/01.cir.101.12.1372","article-title":"Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1097\/HJH.0b013e3283617310","article-title":"Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Hypertension","volume":"31","author":"Schwieler","year":"2013","journal-title":"J. Hypertens."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 Infection: the Perspectives on Immune Responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ"},{"key":"B186","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/s0140-6736(01)07186-0","article-title":"Blood-pressure Reduction and Cardiovascular Risk in HOPE Study","volume":"358","author":"Sleight","year":"2001","journal-title":"The Lancet"},{"key":"B187","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0735-1097(99)00318-6","article-title":"Angiotensin-converting Enzyme Inhibition Reduces Monocyte Chemoattractant Protein-1 and Tissue Factor Levels in Patients with Myocardial Infarction","volume":"34","author":"Soejima","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"B188","first-page":"2628","article-title":"Effects of Telmisartan on Inflammation and Fibrosis after Acute Myocardial Infarction in Rats","volume":"94","author":"Song","year":"2014","journal-title":"Zhonghua yi xue za zhi"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cphy.c130040","article-title":"Classical Renin-Angiotensin System in Kidney Physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr. Physiol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1055\/s-0040-1710018","article-title":"COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb. Haemost."},{"key":"B191","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/hr.2010.67","article-title":"Telmisartan, an Angiotensin-II Receptor Blocker Ameliorates Cardiac Remodeling in Rats with Dilated Cardiomyopathy","volume":"33","author":"Sukumaran","year":"2010","journal-title":"Hypertens. Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"e13280","DOI":"10.1111\/apha.13280","article-title":"Anti\u2010fibrotic Mechanisms of Angiotensin AT2\u2010receptor Stimulation","volume":"227","author":"Sumners","year":"2019","journal-title":"Acta Physiol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1601","article-title":"Mast Cells Promote Atherosclerosis by Releasing Proinflammatory Cytokines","volume":"13","author":"Sun","year":"2007","journal-title":"Nat. Med."},{"key":"B194","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ. Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1172\/jci116234","article-title":"Agonist-mediated Tissue Factor Expression in Cultured Vascular Smooth Muscle Cells. Role of Ca2+ Mobilization and Protein Kinase C Activation","volume":"91","author":"Taubman","year":"1993","journal-title":"J. Clin. Invest."},{"key":"B197","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.1074\/jbc.M410396200","article-title":"A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2","volume":"280","author":"Tchougounova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B198","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/01.cir.98.21.2241","article-title":"High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor","volume":"98","author":"Th\u00f6gersen","year":"1998","journal-title":"Circulation"},{"key":"B199","doi-asserted-by":"publisher","first-page":"172403","DOI":"10.1016\/j.ejphar.2019.05.032","article-title":"ASB17061, a Novel Chymase Inhibitor, Prevented the Development of Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice","volume":"856","author":"Tomimori","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1139\/y02-164","article-title":"Redox-dependent MAP Kinase Signaling by Ang II in Vascular Smooth Muscle Cells: Role of Receptor Tyrosine Kinase Transactivation","volume":"81","author":"Touyz","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07128-0","article-title":"Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?","author":"Tscharre","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B202","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1097\/00004872-200111000-00010","article-title":"Angiotensin(1-7) Potentiates Bradykinin-Induced Vasodilatation in Man","volume":"19","author":"Ueda","year":"2001","journal-title":"J. Hypertens."},{"key":"B203","doi-asserted-by":"publisher","first-page":"22348","DOI":"10.1016\/s0021-9258(18)45712-2","article-title":"Identification of a Highly Specific Chymase as the Major Angiotensin II-Forming Enzyme in the Human Heart","volume":"265","author":"Urata","year":"1990","journal-title":"J. Biol. Chem."},{"key":"B204","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1055\/s-2001-18868","article-title":"Regulatory Role of Cytokines in Disseminated Intravascular Coagulation","volume":"27","author":"van der Poll","year":"2001","journal-title":"Semin. Thromb. Hemost."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1084\/jem.179.4.1253","article-title":"Elimination of Interleukin 6 Attenuates Coagulation Activation in Experimental Endotoxemia in Chimpanzees","volume":"179","author":"van der Poll","year":"1994","journal-title":"J. Exp. Med."},{"key":"B206","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.cir.90.1.362","article-title":"Angiotensin II Increases Plasminogen Activator Inhibitor Type 1 and Tissue-type Plasminogen Activator Messenger RNA in Cultured Rat Aortic Smooth Muscle Cells","volume":"90","author":"van Leeuwen","year":"1994","journal-title":"Circulation"},{"key":"B207","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/s0140-6736(20)30937-5","article-title":"Endothelial Cell Infection and Endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"The Lancet"},{"key":"B208","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/s0895-7061(01)02273-7","article-title":"Angiotensin and Vascular Fibrinolytic Balance","volume":"15","author":"Vaughan","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"B209","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-9560-7-15","article-title":"Hemostasis and Inflammation: Two of a Kind?","volume":"7","author":"Verhamme","year":"2009","journal-title":"Thromb. J."},{"key":"B210","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/01.cir.0000029802.88087.5e","article-title":"A Self-Fulfilling Prophecy","volume":"106","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"B211","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.hyp.0000034738.79310.06","article-title":"Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"B212","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/qjmed\/hcr190","article-title":"Should All Patients at High Cardiovascular Risk Receive Renin-Angiotensin System Blockers?","volume":"105","author":"Volpe","year":"2012","journal-title":"Qjm"},{"key":"B213","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/circulationaha.120.047049","article-title":"Angiotensin Converting Enzyme 2","volume":"142","author":"Wang","year":"2020","journal-title":"Circulation"},{"key":"B214","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fphar.2017.00564","article-title":"Anti-fibrotic Potential of AT2 Receptor Agonists","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1172\/jci39345","article-title":"Mast Cell Chymase Limits the Cardiac Efficacy of Ang I-Converting Enzyme Inhibitor Therapy in Rodents","volume":"120","author":"Wei","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B216","doi-asserted-by":"publisher","first-page":"H2254","DOI":"10.1152\/ajpheart.00191.2001","article-title":"Differential ANG II Generation in Plasma and Tissue of Mice with Decreased Expression of the ACE Gene","volume":"282","author":"Wei","year":"2002","journal-title":"Am. J. Physiology-Heart Circulatory Physiol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.cir.103.3.448","article-title":"Angiotensin II-Induced Hypertension Accelerates the Development of Atherosclerosis in apoE-Deficient Mice","volume":"103","author":"Weiss","year":"2001","journal-title":"Circulation"},{"key":"B218","doi-asserted-by":"publisher","first-page":"54290","DOI":"10.18632\/oncotarget.11091","article-title":"NLRP3 Inflammasome Activation Is Involved in Ang II-Induced Kidney Damage via Mitochondrial Dysfunction","volume":"7","author":"Wen","year":"2016","journal-title":"Oncotarget"},{"key":"B219","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast Cell Secretory Granules: Armed for Battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11906-002-0055-9","article-title":"Angiotensin and Cytoskeletal Proteins: Role in Vascular Remodeling","volume":"4","author":"Wesselman","year":"2002","journal-title":"Curr. Sci. Inc"},{"key":"B221","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.metabol.2012.12.012","article-title":"Renin Inhibition and AT1R Blockade Improve Metabolic Signaling, Oxidant Stress and Myocardial Tissue Remodeling","volume":"62","author":"Whaley-Connell","year":"2013","journal-title":"Metabolism"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/01.hyp.37.4.1136","article-title":"Angiotensin-(1-7) Does Not Affect Vasodilator or TPA Responses to Bradykinin in Human Forearm","volume":"37","author":"Wilsdorf","year":"2001","journal-title":"Hypertension"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of Fibrosis: Therapeutic Translation for Fibrotic Disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and Molecular Mechanisms of Fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/hypertensionaha.110.150029","article-title":"Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Growth Are Mediated by Cytochrome P450 1B1-dependent Superoxide Generation","volume":"55","author":"Yaghini","year":"2010","journal-title":"Hypertension"},{"key":"B226","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/nejm200001203420301","article-title":"Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B227","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3760\/cma.j.issn.0253-2727.2020.008","article-title":"Clinical and Coagulation Characteristics in 7 Patients with Critical COVID-2019 Pneumonia and Acro-Ischemia","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B228","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/antiox9070586","article-title":"The NADPH Oxidase Isoform 1 Contributes to Angiotensin II-Mediated DNA Damage in the Kidney","volume":"9","author":"Zimnol","year":"2020","journal-title":"Antioxidants"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.640185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T20:09:53Z","timestamp":1699128593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.640185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":228,"alternative-id":["10.3389\/fphar.2021.640185"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.640185","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"article-number":"640185"}}